Essential uses: Metered-dose inhalers (MDIs)
- Decision VIII/10: Actions by Parties not operating under Article 5 to promote industry's participation on a smooth and efficient transition away from CFC-based MDIs
- Decision VIII/11: Measures to facilitate a transition by a Party not operating under Article 5 from CFC-based MDIs
- Decision VIII/12: Information gathering on a transition to non-CFC treatments for asthma and chronic obstructive pulmonary disease for Parties not operating under Article 5
- Decision IX/19: Metered-dose inhalers (MDIs)
- Decision IX/20: Transfer of essential-use authorizations for CFCs for MDIs
- Decision XII/2: Measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers
- Decision XIII/9: Metered-dose inhaler (MDI) production
- Decision XIII/10: Further study of campaign production of CFCs for metered-dose inhalers (MDIs)
- Decision XIV/4: Essential-use nominations for non-Article 5 Parties for controlled substances for 2003 and 2004
- Decision XIV/5: Global database and assessment to determine appropriate measures to complete the transition from chlorofluorocarbon metered-dose inhalers
- Decision XV/4: Essential use nominations for non-Article 5 Parties for controlled substances for 2004 and 2005
- Decision XV/5: Promoting the closure of essential-use nominations for metered-dose inhalers
- Decision XVI/12: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006
- Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007
- Decision XVII/14: Difficulties faced by some Parties operating under paragraph 1 of Article 5 of the Montreal Protocol with respect to chlorofluorocarbons used in the manufacture of metered-dose inhalers
- Decision XVIII/7: Essential-use exemptions for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2007 and 2008
- Decision XVIII/16: Difficulties faced by some Article 5 Parties manufacturing metered-dose inhalers which use chlorofluorocarbons
- Decision XIX/13: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2008 and 2009
- Decision XX/2: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2009 and 2010
- Decision XX/3: Essential-use exemptions for Parties operating under paragraph 1 of Article 5
- Decision XX/4: Campaign production of chlorofluorocarbons for metered-dose inhalers
- Decision XXI/4: Essential-use nominations for controlled substances for 2010
- Decision XXII/4: Essential-use nominations for controlled substances for 2011
- Decision XXIII/2: Essential-use nominations for controlled substances for 2012
- Decision XXIV/3 : Essential-use nominations for controlled substances for 2013
- Decision XXV/2 : Essential-use nominations for controlled substances for 2014
- Decision XXVI/2 : Essential-use nominations for controlled substances for 2015